material
PET support
PVDF
polyester support
Quality Level
Agency
meets USP Biological Reactivity Test for class VI plastics (family component materials)
sterility
sterile; γ-irradiated (level of 25-40kGy)
flow rate measuring range
10 L/min (/m2)
parameter
1 psi max. reverse press. exposure at 25 °C
1-2.5 L process volume
15 psi at 25 °C (max. burst pressure)
5 psi max. inlet pressure at 25 °C
filtration area
0.01 m2
membrane filtration area
0.01 m2
pore size
5 μm pore size
storage temp.
15-25°C
Looking for similar products? Visit Product Comparison Guide
General description
Application
Seed Train Perfusion
Features and Benefits
Other Notes
Legal Information
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.
This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.
Related Content
Learn more on mAB bioreactor production, and the products you need for this step.
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Các nhà phát triển dược phẩm sinh học cần các quá trình ngược dòng hiệu quả, hiệu quả cung cấp các kháng thể đơn dòng chất lượng cao (mAbs) và các loại protein tái tổ hợp khác. Tăng cường quy trình có thể chứng minh cho các chiến lược sản xuất của họ trong tương lai, giảm chi phí và tăng tính linh hoạt của nhà máy.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service